Aimaz Afrough
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
-
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 26
- Multiple Myeloma Research and Treatments 19
- Hematopoietic Stem Cell Transplantation 4
- Chronic Myeloid Leukemia Treatments 4
- Oncology 14
- CAR-T cell therapy research 8
- Peptidase Inhibition and Analysis 5
- Co-authors
- Richard E. Champlin (7 shared papers)Hamza Hashmi (12 shared papers)Zahra Mahmoudjafari (8 shared papers)Gabriela Rondón (4 shared papers)Al‐Ola Abdallah (10 shared papers)Amir Hamdi (5 shared papers)Uday Popat (8 shared papers)Leyla Shune (8 shared papers)
- Journals
- Blood (10 papers)Biology of Blood and Marrow Transplantation (4 papers)Journal of Clinical Oncology (4 papers)Transplantation and Cellular Therapy (4 papers)Hematological Oncology (1 paper)
- Partner nations
- United StatesAzerbaijanIsrael
In The Last Decade
Aimaz Afrough
27 papers receiving 218 citations
Peers
Comparison fields: 5 of 30
- Hematology 119
- Oncology 79
- Genetics 21
- Hepatology 14
- Public Health, Environmental and Occupational Health 30
Countries citing papers authored by Aimaz Afrough
This map shows the geographic impact of Aimaz Afrough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimaz Afrough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimaz Afrough more than expected).
Fields of papers citing papers by Aimaz Afrough
This network shows the impact of papers produced by Aimaz Afrough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimaz Afrough. The network helps show where Aimaz Afrough may publish in the future.
Co-authors
The 25 scholars most cited alongside Aimaz Afrough, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 42 | |
| 2 | 2014 | 37 | |
| 3 | 2014 | 18 | |
| 4 | 2018 | 18 | |
| 5 | 2017 | 14 | |
| 6 | 2019 | 12 | |
| 7 | 2022 | 11 | |
| 8 | 2023 | 8 | |
| 9 | 2024 | 8 | |
| 10 | 2023 | 6 | |
| 11 | 2016 | 6 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2015 | 5 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2014 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2022 | 2 |
About Aimaz Afrough
Aimaz Afrough is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Epidemiology, having authored 35 papers that have together received 220 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (19 papers), CAR-T cell therapy research (8 papers), Protein Degradation and Inhibitors (5 papers), Peptidase Inhibition and Analysis (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers). The work is most often cited by research in Hematology (119 citations), Oncology (79 citations), Genetics (21 citations), Hepatology (14 citations) and Public Health, Environmental and Occupational Health (30 citations). Aimaz Afrough has collaborated with scholars based in United States, Azerbaijan and Israel. Frequent co-authors include Richard E. Champlin, Hamza Hashmi, Zahra Mahmoudjafari, Gabriela Rondón, Al‐Ola Abdallah, Amir Hamdi, Uday Popat, Leyla Shune, Aishwarya Sannareddy and Partow Kebriaei. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Transplantation and Cellular Therapy and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.